Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Manson, A. Aragaki, J. Rossouw, G. Anderson, R. Prentice, A. LaCroix, R. Chlebowski, B. Howard, C. Thomson, K. Margolis, C. Lewis, M. Stefanick, R. Jackson, K. Johnson, L. Martin, S. Shumaker, M. Espeland, J. Wactawski‐Wende (2017)
Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women’s Health Initiative Randomized TrialsJAMA, 318
G. Hale, H. Burger (2009)
Hormonal changes and biomarkers in late reproductive age, menopausal transition and menopause.Best practice & research. Clinical obstetrics & gynaecology, 23 1
N. Santoro, A. Allshouse, G. Neal-Perry, L. Pal, Rogerio Lobo, F. Naftolin, Dennis Black, E. Brinton, M. Budoff, Marcelle Cedars, N. Dowling, M. Dunn, Carey Gleason, H. Hodis, Barbara Isaac, M. Magnani, J. Manson, Virginia Miller, Hugh Taylor, W. Wharton, E. Wolff, Viola Zepeda, S. Harman (2017)
Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention StudyMenopause, 24
G. Vilagut, C. Forero, G. Barbaglia, J. Alonso (2016)
Screening for Depression in the General Population with the Center for Epidemiologic Studies Depression (CES-D): A Systematic Review with Meta-AnalysisPLoS ONE, 11
JL Gordon, DR Rubinow, TA Eisenlohr-Moul, K Xia, PJ Schmidt, SS Girdler
Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial [published online January 10, 2018]
H. Joffe, S. Crawford, M. Freeman, D. White, M. Bianchi, Semmie Kim, N. Economou, Julie Camuso, J. Hall, L. Cohen (2016)
Independent Contributions of Nocturnal Hot Flashes and Sleep Disturbance to Depression in Estrogen-Deprived Women.The Journal of clinical endocrinology and metabolism, 101 10
J. Bromberger, S. Assmann, N. Avis, M. Schocken, H. Kravitz, A. Cordal (2003)
Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women.American journal of epidemiology, 158 4
E. Freeman, M. Sammel, Hui-Wen Lin, D. Nelson (2006)
Associations of hormones and menopausal status with depressed mood in women with no history of depression.Archives of general psychiatry, 63 4
E. Freeman, M. Sammel, D. Boorman, Rongmei Zhang (2014)
Longitudinal pattern of depressive symptoms around natural menopause.JAMA psychiatry, 71 1
M. Hickey, D. Schoenaker, H. Joffe, G. Mishra (2016)
Depressive symptoms across the menopause transition: findings from a large population-based cohort studyMenopause, 23
J. Pinkerton, F. Aguirre, J. Blake, F. Cosman, H. Hodis, Susan Hoffstetter, A. Kaunitz, S. Kingsberg, P. Maki, J. Manson, P. Marchbanks, M. McClung, L. Nachtigall, L. Nelson, D. Pace, R. Reid, P. Sarrel, J. Shifren, C. Stuenkel, W. Utian (2017)
The 2017 hormone therapy position statement of The North American Menopause SocietyMenopause, 24
S. McCurry, K. Guthrie, C. Morin, N. Woods, C. Landis, K. Ensrud, J. Larson, H. Joffe, L. Cohen, J. Hunt, K. Newton, Julie Otte, S. Reed, B. Sternfeld, L. Tinker, A. LaCroix (2016)
Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial.JAMA internal medicine, 176 7
J. Rossouw, G. Anderson, R. Prentice, A. LaCroix, C. Kooperberg, M. Stefanick, R. Jackson, S. Beresford, B. Howard, K. Johnson, J. Kotchen, J. Ockene (2002)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trialObstetrics & Gynecology, 101
H. Christensen, P. Batterham, J. Gosling, L. Ritterband, K. Griffiths, F. Thorndike, N. Glozier, B. O’Dea, I. Hickie, A. Mackinnon (2016)
Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): a randomised controlled trial.The lancet. Psychiatry, 3 4
Opinion EDITORIAL Should Hormone Therapy Be Used to Prevent Depressive Symptoms During the Menopause Transition? Hadine Joffe, MD, MSc; Martha Hickey, BA(Hons), MBChB, MSc, FRCOG, FRANZCOG, MD In this issue of JAMA Psychiatry, Gordon et al report results of this subgroup (42 women), this observation is consistent with larger prospective studies indicating that the early peri- from a 12-month randomized clinical trial of estrogen plus pro- gestin hormone therapy (HT) vs placebo for the prevention of menopause confers heightened vulnerability to depressive 8,9 depressive symptoms in 172 symptoms, perhaps owing to greater variability in circulat- euthymic perimenopausal ing estradiol concentrations during this reproductive stage. Related article page 149 and early postmenopausal A limitation of this study is that we do not know whether women. Using a random- women who developed elevated Center for Epidemiological ized, parallel-arm placebo-controlled design, they found that Studies Depression Scale scores were experiencing an epi- women assigned to placebo were twice as likely to develop sode of major depression because the sensitivity and speci- clinically significant depressive symptoms compared with ficity of this Center for Epidemiological Studies Depression those randomized to HT. During 12 months of continuous treat- Scale cutoff are 87% and 70%, respectively.
JAMA Psychiatry – American Medical Association
Published: Feb 10, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.